Celularity Inc (CELUW)

Latest Insider Confidence Score

2025Q4

50.0
Bearish

Company insider confidence (by quarter)

2019Q2 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
GX Sponsor LLC — 7,000,000 Jul 20, 2021
Starr International Co Inc — 6,640,694 Mar 15, 2022
Starr International Investments Ltd. — 6,640,694 Mar 15, 2022
Sorrento Therapeutics, Inc. — 5,050,427 Oct 5, 2023
Hariri Robert J CEO 2,855,889 Apr 16, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 27, 2024 Aug 28, 2024 BERMAN RICHARD J Director Neutral 52.5 - 0.00% ✗ -
Aug 28, 2024 BERMAN RICHARD J Director Neutral 52.5 - 0.00% ✗ -
Apr 13, 2024 Apr 16, 2024 Fletcher Kyle Officer Sell 52.5 -20 -0.09% ✗ $82.2
Apr 13, 2024 Apr 16, 2024 Haines John R Officer Sell 27.5 -576 -1.48% ✗ $2.4K
Apr 13, 2024 Apr 16, 2024 Beers David C CFO Sell 27.5 -360 -1.48% ✗ $1.5K
Apr 13, 2024 Apr 16, 2024 Hariri Robert J CEO Sell 52.5 -1,154 -0.04% ✗ $4.7K
Apr 13, 2024 Apr 16, 2024 Brigido Stephen Pres, Functional Regeneration Sell 27.5 -268 -1.36% ✗ $1.1K
Mar 15, 2024 Mar 19, 2024 Fletcher Kyle Officer Sell 27.5 -617 -2.84% ✗ $3.5K
Mar 13, 2024 Mar 15, 2024 Lim Kok Thay 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 16, 2024 Feb 21, 2024 Hariri Robert J CEO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2024 Feb 21, 2024 Kilcoyne Adrian Chief Medical Officer Sell 26.3 -52,762 -4.49% ✗ $22.9K
Feb 17, 2024 Feb 21, 2024 Haines John R Officer Sell 26.3 -70,350 -15.30% ✗ $30.5K
Feb 17, 2024 Feb 21, 2024 Beers David C CFO Sell 26.3 -43,968 -15.30% ✗ $19.1K
Feb 17, 2024 Feb 21, 2024 Brigido Stephen Pres, Functional Regeneration Sell 26.3 -32,720 -14.22% ✗ $14.2K
Feb 17, 2024 Feb 21, 2024 Fletcher Kyle Officer Sell 26.3 -39,571 -15.41% ✗ $17.2K
Jan 12, 2024 Jan 17, 2024 Lim Kok Thay 10% Owner Buy 100.0 +21,410,983 71.14% ✗ $5.3M
Aug 31, 2023 Oct 16, 2023 Ling Geoffrey M.D. Director Neutral 52.5 - 0.00% ✗ -
Oct 16, 2023 Ling Geoffrey M.D. Director Neutral 52.5 - 0.00% ✗ -
Sep 29, 2023 Oct 10, 2023 Hariri Robert J CEO Buy 100.0 +18,422,124 181.53% ✗ $3M
Sep 29, 2023 Oct 5, 2023 Sorrento Therapeutics, Inc. 10% Owner Neutral 27.5 -15,371,697 -75.27% ✗ -
Jul 14, 2023 Jul 19, 2023 Kilcoyne Adrian Chief Medical Officer Neutral 90.0 +875,000 291.67% ✗ -
Jun 14, 2023 Jun 30, 2023 Lim Kok Thay Director Sell 47.5 -10,844 -4.59% ✗ $8.1K
Jun 20, 2023 Jun 22, 2023 Genting Berhad 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Parks Diane L. Director Neutral 90.0 +199,921 553.11% ✗ -
Jun 14, 2023 Jun 16, 2023 Kehler Dean C Director Neutral 90.0 +199,921 553.11% ✗ -
Jun 14, 2023 Jun 16, 2023 Smith Robin L Director Neutral 90.0 +199,921 553.11% ✗ -
Jun 14, 2023 Jun 16, 2023 Mazur Marc Director Neutral 90.0 +199,921 553.11% ✗ -
Jun 14, 2023 Jun 16, 2023 VON ESCHENBACH ANDREW C. Director Neutral 90.0 +199,921 146.84% ✗ -
Jun 14, 2023 Jun 16, 2023 SCULLEY JOHN Director Neutral 90.0 +199,921 24.84% ✗ -
Jun 14, 2023 Jun 16, 2023 Diamandis Peter Director Neutral 90.0 +199,921 18.06% ✗ -
Jun 14, 2023 Jun 16, 2023 Lim Kok Thay Director Neutral 90.0 +199,921 553.11% ✗ -
Apr 13, 2023 Apr 17, 2023 Brigido Stephen Pres, Functional Regeneration Sell 47.5 -2,683 -1.15% ✗ $1.9K
Apr 13, 2023 Apr 17, 2023 Fletcher Kyle Officer Sell 52.5 -201 -0.08% ✗ $143.5
Apr 13, 2023 Apr 17, 2023 Hariri Robert J CEO Sell 52.5 -11,540 -0.11% ✗ $8.2K
Apr 13, 2023 Apr 17, 2023 Beers David C CFO Sell 47.5 -3,606 -1.24% ✗ $2.6K
Apr 13, 2023 Apr 17, 2023 Haines John R Officer Sell 47.5 -5,770 -1.24% ✗ $4.1K
Apr 13, 2023 Apr 17, 2023 Glover Bradley Officer Sell 50.0 -2,884 -0.81% ✗ $2.1K
Mar 15, 2023 Mar 30, 2023 Fletcher Kyle Officer Sell 50.0 -2,170 -0.84% ✗ $1.4K
Mar 27, 2023 Mar 27, 2023 Hariri Robert J CEO Neutral 90.0 +2,084,854 25.82% ✗ -
Feb 17, 2023 Feb 22, 2023 Fletcher Kyle Officer Neutral 90.0 +225,000 658.47% ✗ -
Feb 17, 2023 Feb 22, 2023 Haines John R President Neutral 90.0 +400,000 609.60% ✗ -
Feb 17, 2023 Feb 22, 2023 Beers David C CFO Neutral 90.0 +250,000 609.59% ✗ -
Feb 17, 2023 Feb 22, 2023 Glover Bradley Officer Neutral 90.0 +300,000 554.77% ✗ -
Feb 17, 2023 Feb 22, 2023 Brigido Stephen Pres, Functional Regeneration Neutral 90.0 +200,000 609.59% ✗ -
Feb 17, 2023 Feb 22, 2023 Kilcoyne Adrian Chief Medical Officer Neutral 90.0 +300,000 100.00% ✗ -
Feb 10, 2023 Feb 14, 2023 Diamandis Peter Director Neutral 52.5 - 0.00% ✗ -
Nov 30, 2022 Nov 30, 2022 Hariri Robert J CEO Buy 56.3 +10,000 0.12% ✗ $17.2K
Nov 29, 2022 Nov 29, 2022 Hariri Robert J CEO Buy 65.0 +40,000 0.50% ✗ $68.4K
Nov 28, 2022 Nov 28, 2022 Hariri Robert J CEO Buy 72.5 +40,000 0.50% ✗ $69.6K
Nov 16, 2021 Nov 18, 2022 Jones Anne Chief Business Officer Sell 90.0 +21,266 76.26% ✗ $7.1K
Nov 16, 2022 Nov 18, 2022 Fletcher Kyle General Counsel Sell 47.5 -1,262 -3.56% ✗ $2.4K
Nov 16, 2021 Nov 18, 2022 Glover Bradley Officer Sell 90.0 +21,266 64.82% ✗ $7.1K
Oct 3, 2022 Oct 4, 2022 Kilcoyne Adrian Officer Neutral 52.5 - 0.00% ✗ -
Oct 4, 2022 Kilcoyne Adrian Officer Neutral 52.5 - 0.00% ✗ -
Aug 26, 2022 Aug 30, 2022 SCULLEY JOHN Director Neutral 52.5 - 0.00% ✗ -
Aug 24, 2022 Aug 25, 2022 Hariri Robert J CEO Neutral 52.5 - 0.00% ✗ -
Aug 16, 2022 Aug 18, 2022 Smith Robin L Director Neutral 52.5 - 0.00% ✗ -
Jul 13, 2022 Jul 15, 2022 Diamandis Peter Director Neutral 90.0 +36,145 100.00% ✗ -
Jul 13, 2022 Jul 15, 2022 SCULLEY JOHN Director Neutral 90.0 +36,145 100.00% ✗ -
Jul 13, 2022 Jul 15, 2022 Lim Kok Thay Director Neutral 90.0 +36,145 100.00% ✗ -
Jul 13, 2022 Jul 15, 2022 Kehler Dean C Director Neutral 90.0 +36,145 100.00% ✗ -
Jul 13, 2022 Jul 15, 2022 Glover Bradley Chief Technology Officer Neutral 90.0 +13,124 66.67% ✗ -
Jul 13, 2022 Jul 15, 2022 Mazur Marc Director Neutral 90.0 +36,145 100.00% ✗ -
Jul 13, 2022 Jul 15, 2022 Parks Diane L. Director Neutral 90.0 +36,145 100.00% ✗ -
Jul 13, 2022 Jul 15, 2022 Jones Anne Chief Business Officer Neutral 90.0 +11,483 70.00% ✗ -
Jul 13, 2022 Jul 15, 2022 Fletcher Kyle General Counsel Neutral 85.0 +2,297 6.93% ✗ -
Jul 13, 2022 Jul 15, 2022 Smith Robin L Director Neutral 90.0 +36,145 100.00% ✗ -
Jul 13, 2022 Jul 15, 2022 VON ESCHENBACH ANDREW C. Director Neutral 90.0 +36,145 36.15% ✗ -
Jul 15, 2022 Fletcher Kyle General Counsel Neutral 52.5 - 0.00% ✗ -
Jun 2, 2022 Jun 3, 2022 Parks Diane L. Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2022 Parks Diane L. Director Neutral 52.5 - 0.00% ✗ -
Apr 13, 2022 Apr 28, 2022 Haines John R Officer Neutral 90.0 +65,617 100.00% ✗ -
Apr 13, 2022 Apr 28, 2022 Hariri Robert J CEO Neutral 77.5 +131,234 1.70% ✗ -
Apr 13, 2022 Apr 28, 2022 Dunn Keary Officer Neutral 90.0 +16,405 100.00% ✗ -
Apr 13, 2022 Apr 28, 2022 Brigido Stephen Pres, Functional Regeneration Neutral 90.0 +32,809 100.00% ✗ -
Apr 13, 2022 Apr 28, 2022 Beers David C CFO Neutral 90.0 +41,011 100.00% ✗ -
Apr 13, 2022 Apr 28, 2022 Glover Bradley Chief Technology Officer Neutral 90.0 +19,686 100.00% ✗ -
Apr 13, 2022 Apr 28, 2022 Jones Anne Chief Business Officer Neutral 90.0 +16,405 100.00% ✗ -
Mar 1, 2022 Mar 15, 2022 STARR INTERNATIONAL CO INC 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 9, 2021 Dec 2, 2021 VON ESCHENBACH ANDREW C. Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2021 Sep 17, 2021 Pecora Andrew L President Neutral 52.5 - 0.00% ✗ -
Sep 17, 2021 Pecora Andrew L President Neutral 52.5 - 0.00% ✗ -
Sep 13, 2021 Sep 15, 2021 Mirakhur Beloo EVP, Clinical Development Neutral 52.5 - 0.00% ✗ -
Sep 15, 2021 Mirakhur Beloo EVP, Clinical Development Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Brigido Stephen Pres, Functional Regeneration Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Smith Robin L Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Hariri Robert J CEO Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Diamandis Peter Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Mazur Marc Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Lim Kok Thay Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Dunn Keary General Counsel & EVP Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 SCULLEY JOHN Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Haines John R Chief Ops & Admin Officer Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Bloom Jay R Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Kehler Dean C Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 Beers David C CFO Neutral 52.5 - 0.00% ✗ -
Sep 9, 2021 Sep 13, 2021 VON ESCHENBACH ANDREW C. Director Neutral 52.5 - 0.00% ✗ -
Aug 3, 2021 STARR INTERNATIONAL CO INC 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 26, 2021 Dragasac Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 26, 2021 STARR INTERNATIONAL CO INC 10% Owner Neutral 52.5 - 0.00% ✗ -